These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line. Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997 [TBL] [Abstract][Full Text] [Related]
4. The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization. Tóthová Z; Šemeláková M; Solárová Z; Tomc J; Debeljak N; Solár P Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299300 [TBL] [Abstract][Full Text] [Related]
5. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling. Held MA; Greenfest-Allen E; Su S; Stoeckert CJ; Stokes MP; Wojchowski DM Cell Signal; 2020 May; 69():109554. PubMed ID: 32027948 [TBL] [Abstract][Full Text] [Related]
6. Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathways. Um M; Lodish HF J Biol Chem; 2006 Mar; 281(9):5648-56. PubMed ID: 16407271 [TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells. Sakamoto H; Kitamura T; Yoshimura A J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479 [TBL] [Abstract][Full Text] [Related]
8. Association of JAK2 and STAT5 with erythropoietin receptors. Role of receptor phosphorylation in erythropoietin signal transduction. Sawyer ST; Penta K J Biol Chem; 1996 Dec; 271(50):32430-7. PubMed ID: 8943308 [TBL] [Abstract][Full Text] [Related]
9. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3. Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755 [TBL] [Abstract][Full Text] [Related]
10. Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis. Ueda F; Tago K; Tamura H; Funakoshi-Tago M J Biol Chem; 2017 Feb; 292(5):1826-1846. PubMed ID: 27998978 [TBL] [Abstract][Full Text] [Related]
11. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells. Yamamura Y; Senda H; Kageyama Y; Matsuzaki T; Noda M; Ikawa Y Mol Cell Biol; 1998 Mar; 18(3):1172-80. PubMed ID: 9488432 [TBL] [Abstract][Full Text] [Related]
12. Effects of supplemental erythropoietin on its receptor expression and signal transduction pathways in rat model of retinal detachment. Xie Z; Chen F; Wu X; Zhuang C; Zhu J; Wang J; Ji H; Wang Y; Hua X Curr Eye Res; 2012 Feb; 37(2):138-44. PubMed ID: 22251399 [TBL] [Abstract][Full Text] [Related]
13. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation. Arcasoy MO; Harris KW; Forget BG Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445 [TBL] [Abstract][Full Text] [Related]
14. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. Sasaki A; Yasukawa H; Shouda T; Kitamura T; Dikic I; Yoshimura A J Biol Chem; 2000 Sep; 275(38):29338-47. PubMed ID: 10882725 [TBL] [Abstract][Full Text] [Related]
15. Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2. Grebien F; Kerenyi MA; Kovacic B; Kolbe T; Becker V; Dolznig H; Pfeffer K; Klingmüller U; Müller M; Beug H; Müllner EW; Moriggl R Blood; 2008 May; 111(9):4511-22. PubMed ID: 18239084 [TBL] [Abstract][Full Text] [Related]
16. Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin. Byts N; Samoylenko A; Fasshauer T; Ivanisevic M; Hennighausen L; Ehrenreich H; Sirén AL Cell Death Differ; 2008 Apr; 15(4):783-92. PubMed ID: 18259195 [TBL] [Abstract][Full Text] [Related]
17. Erythropoietin Rescues Memory Impairment in a Rat Model of Chronic Cerebral Hypoperfusion via the EPO-R/JAK2/STAT5/PI3K/Akt/GSK-3β Pathway. Ma S; Chen J; Chen C; Wei N; Xu J; Yang G; Wang N; Meng Y; Ren J; Xu Z Mol Neurobiol; 2018 Apr; 55(4):3290-3299. PubMed ID: 28488208 [TBL] [Abstract][Full Text] [Related]
18. Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells. Ammarguellat F; Llovera M; Kelly PA; Goffin V Biochem Biophys Res Commun; 2001 Jun; 284(4):1031-8. PubMed ID: 11409898 [TBL] [Abstract][Full Text] [Related]
19. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis. Wakao H; Chida D; Damen JE; Krystal G; Miyajima A Biochem Biophys Res Commun; 1997 May; 234(1):198-205. PubMed ID: 9168989 [TBL] [Abstract][Full Text] [Related]
20. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway. Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]